HARP Insider Trading Activity and SEC Form 4 Filings
HARP insider trading summary
No open-market insider purchases or sales of Harpoon Therapeutics, Inc. (HARP) have been reported on SEC Form 4 in the past 12 months.
Latest HARP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 11, 2024 | Merck & Co., Inc. | Insider | Buy | $492.1M (21,397,205 @ $23.00) |
| Mar 11, 2024 | Merck Sharp & Dohme LLC | Insider | Buy | $492.1M (21,397,205 @ $23.00) |
| Oct 25, 2023 | New Leaf Ventures III, L.P. | 10% Owner | Buy | $0 (1,372,000 @ $0.00) |
| Oct 25, 2023 | New Leaf Venture Management III, L.L.C. | 10% Owner | Buy | $0 (1,372,000 @ $0.00) |
| Oct 25, 2023 | Vijay K Lathi | 10% Owner | Buy | $0 (1,372,000 @ $0.00) |
| Oct 25, 2023 | New Leaf Venture Associates III, L.P. | 10% Owner | Buy | $0 (1,372,000 @ $0.00) |
| Oct 25, 2023 | New Leaf BPO Associates II, L.P. | 10% Owner | Buy | $0 (171,500 @ $0.00) |
| Oct 25, 2023 | New Leaf BPO Associates II, L.P. | 10% Owner | Buy | $0 (1,372,000 @ $0.00) |
| Oct 25, 2023 | New Leaf BPO Management II, L.L.C | 10% Owner | Buy | $0 (1,372,000 @ $0.00) |
| Oct 25, 2023 | New Leaf Biopharma Opportunities II, L.P. | 10% Owner | Buy | $0 (1,372,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.